• AAPL 165
  • TSLA 147.05
  • AMZN 174.63
  • MSFT 399.12
  • INTC 34.2
  • EURUSD 1.0661
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. ST /
  3. ACE.ST

Ascelia Pharma AB (publ) (ACE ST) stock market data APIs

kr13.69 0.51(3.9%) as of April 19, 2024

Ascelia Pharma AB (publ) Financial Data Overview

13.56
13.69
-
14.45
12.91
2.62-17.5
445 M
33 758 K
0
-0.31
1.08
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ACE',
Type: 'Common Stock',
Name: 'Ascelia Pharma AB (publ)',
Exchange: 'ST',
CurrencyCode: 'SEK',
CurrencyName: 'Swedish krone',
CurrencySymbol: 'kr',
CountryName: 'Sweden',
CountryISO: 'SE',
OpenFigi: NULL,
ISIN: 'SE0010573113',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Ascelia Pharma AB (publ) Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -111 401 000
  • Earnings Per Share -3.24
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Ascelia Pharma AB (publ) Earnings via APIs

  • Latest Release 2024-02-09
  • EPS/Forecast -0.5

Get Ascelia Pharma AB (publ) End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Ascelia Pharma AB (publ) latest news via APIs

Trade Alert: The Director Of Ascelia Pharma AB (publ) (STO:ACE), Niels Mengel, Has Just Spent kr204k Buying 42% More Shares

Whilst it may not be a huge deal, we thought it was good to see that the Ascelia Pharma AB (publ) (STO:ACE) Director, Niels Mengel, recently bought kr204k worth of stock, for kr20.38 per share. While ...
  • ASCELIA PHARMA
  • INSIDER TRANSACTIONS

We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenu...
  • ASCELIA PHARMA
  • FREE CASH FLOW
  • PHARMA
Do you have any questions?
support@eodhistoricaldata.com